Alector, Inc. (ALEC)
$1.87-10.10%Close
SELLRECOVERY · day 5
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $208M
- Beta
- 0.62
- P/E (TTM)
- -1.70
- Short % float
- 7.91%
- Days to cover
- 5.7
- SI change
- +0.7%
- 1W
- +3.31%
- 1M
- -15.38%
- vs SPY 1W
- +3.45%
- vs SPY 1M
- -17.89%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on ALEC?
- LOPJLB’s latest quantitative signal on Alector, Inc. (ALEC) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is ALEC in?
- Alector, Inc. (ALEC) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Alector, Inc. (ALEC) do?
- Alector, Inc. operates as a clinical-stage biopharmaceutical company, which engages in pioneering of immuno-neurology. It develops portfolio of innate immune system programs, designed to functionally repair genetic mutations and enable the rejuvenated immune cells to counteract emerging brain pathologies. Its treatment targets immune dysfunction as a root cause of multiple pathologies that are …